Skip to content
Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease episode artwork

Apr 29, 2020 1 min

Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease

from The JRHEUM Podcast Hosted by The Journal of Rheumatology

Audio abstract for the published article: Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease: A Comparison of Scleroderma Lung Study I and II by Elizabeth R. Volkmann, Donald P. Tashkin, Myung Sim, Ning Li, Dinesh Khanna, Michael D. Roth, Philip J. Clements, Anna-Maria Hoffmann-Vold, Daniel E. Furst, Grace Kim, Jonathan Goldin and Robert M. Elashoff The Journal of Rheumatology October 2019, 46 (10) 1316-1325; DOI: https://doi.org/10.3899/jrheum.180441

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease

0:00 1:34

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of The JRHEUM Podcast?

This episode is 1 minute long.

When was this The JRHEUM Podcast episode published?

This episode was published on April 29, 2020.

Can I download this The JRHEUM Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.